Global Exosome Therapy Market to Reach $2.5 Billion by 2030, Driven by Aesthetics and Longevity
【Abstract】: (Market Trend) A new report by Grand View Research values the global exosome therapeutic market at $800 million in early 2026, projecting a massive surge to $2.5 billion by 2030. The growth is heavily fueled by off-label uses in aesthetic dermatology, hair restoration, and systemic anti-aging clinics, particularly in South Korea and the USA.
Business Insight: Exosomes have officially replaced traditional PRP and early-stage stem cells as the preferred, non-cellular regenerative tool due to easier storage and lower immunogenicity. For aesthetic and longevity clinics at CMTF, integrating clinical-grade exosome protocols is mandatory to capture the high-end regenerative aesthetic market.
【Keywords】: #ExosomeTherapy #RegenerativeAesthetics #LongevityMarket
